Published in Neoplasia on August 24, 2017
Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res (2010) 12.96
ERAD: the long road to destruction. Nat Cell Biol (2005) 7.46
IRE1alpha kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell (2009) 4.65
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol (2012) 3.90
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood (2005) 3.63
c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci U S A (1999) 3.48
Acute lymphoblastic leukaemia. Lancet (2013) 3.44
ER stress-induced cell death mechanisms. Biochim Biophys Acta (2013) 3.07
Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science (2014) 2.59
Acute Lymphoblastic Leukemia in Children. N Engl J Med (2015) 2.33
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. J Clin Invest (2012) 1.85
ER stress transcription factor Xbp1 suppresses intestinal tumorigenesis and directs intestinal stem cells. J Exp Med (2013) 1.70
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis. Cancer Cell (2015) 1.65
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat Chem Biol (2013) 1.65
The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J Cell Sci (2014) 1.32
Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci (2014) 1.30
Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature (1993) 1.27
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2014) 0.95
Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083). J Med Chem (2015) 0.95
How I treat acute lymphoblastic leukemia in older adolescents and young adults. Blood (2015) 0.92
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia. Haematologica (2016) 0.88
Rationale for targeting the pre-B-cell receptor signaling pathway in acute lymphoblastic leukemia. Blood (2015) 0.86
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance. Leukemia (2006) 0.83
Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget (2016) 0.80
The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD). J Biol Chem (2015) 0.78